Clinical Oncology

Article	Citations
International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic	182
Supportive Care: An Indispensable Component of Modern Oncology	60
Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis	56
Beyond Performance Status	52
Machine Learning for Auto-Segmentation in Radiotherapy Planning	43
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic	43
UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy	35
Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Lea	34
Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence	33
Eliminating Cervical Cancer: Progress and Challenges for High-income Countries	32
Image-guided Radiotherapy to Manage Respiratory Motion: Lung and Liver	29
Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment?	28
The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report	26
Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation	26
Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease	26
Image-Guided Radiotherapy for Pelvic Cancers: A Review of Current Evidence and Clinical Utilisation	25
Comparative Analysis of Radiotherapy Linear Accelerator Downtime and Failure Modes in the UK, Nigeria and Botswana	24
Image-guided Adaptive Radiotherapy for Bladder Cancer	24
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy	24
Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation	22
A Review of Modern Radiation Therapy Dose Escalation in Locally Advanced Head and Neck Cancer	22
Falls and Cancer	21
Rapid Access Palliative Radiotherapy Programmes	20
Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review	19
Deep Learning for Radiotherapy Outcome Prediction Using Dose Data – A Review	19

A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam Therapy	19
Incidence, Treatment and Outcomes of Cervical Cancer in Low- and Middle-income Countries	18
Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes	18
Moving Forward Fast with FAST-Forward	18
Improving the Quality of Care in Radiation Oncology using Artificial Intelligence	17
Targeting DNA Repair in Ovarian Cancer Treatment Resistance	17
Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing	17
Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery	16
Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England	16
Comparing Proton to Photon Radiotherapy Plans: UK Consensus Guidance for Reporting Under Uncertainty for Clinical Trials	16
The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation Trust	16
Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma – Initial Experience From an Australian Liver Cancer Service	15
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III	15
Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer	15
Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up	15
Laparoscopic and Robotic Surgery for Endometrial and Cervical Cancer	15
Current Status and Future Direction of Hepatic Radioembolisation	15
Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group	15
Structure and Processes of Existing Practice in Radiotherapy Peer Review: A Systematic Review of the Literature	15
Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020	14
Palliative Radiation Therapy in Older Adults With Cancer: Age-Related Considerations	14
Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based Chemotherapy	14
Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas – A Single Institution Phase II Study	14
How Low Can You Go? The Radiobiology of Hypofractionation	14
Advancing Roles of Healthcare Professionals in Palliative Radiotherapy	14
Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences	14
An Overview of Treating People with Comorbid Dementia: Implications for Cancer Care	14
The Pivotal Role of the Therapeutic Radiographer/Radiation Therapist in Image-guided Radiotherapy Research and Development	13
Hypoxia and its Modification in Bladder Cancer: Current and Future Perspectives	13
Advanced Cancer Patients' Prognostic Awareness and Its Association With Anxiety, Depression and Spiritual Well-Being: A Multi-Country Study in Asia	13
The Metaverse and Oncology	13
Radiation-Induced Sarcoma: A Retrospective Population-Based Study Over 34 Years in a Single Institution	13
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma	13
Salvage Radiotherapy for Prostate Cancer	13
Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment	13
Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore	12
Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults	12
Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review	12
Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?	12
HERMES: Delivery of a Speedy Prostate Cancer Treatment	12
Therapeutic Modification of Hypoxia	12
The Development of Therapeutic Radiographers in Imaging and Adaptive Radiotherapy Through Clinical Trial Quality Assurance	12
Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies	12
Advances in External Beam Radiation Therapy and Brachytherapy for Cervical Cancer	12
Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation	12
Adjuvant and Neoadjuvant Radiation Therapy for Locally Advanced Bladder Cancer	12
Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung – The Knockout Punch	12
Impaired Geriatric 8 Score is Associated with Worse Survival after Radiotherapy in Older Patients with Cancer	12
Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic	12
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group	11

Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer	11
Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic	11
Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life	11
Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases f	11
A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy	11
Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study	11
Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consen	11
Systemic Radiotherapy of Bone Metastases With Radionuclides	11
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?	11
Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study	11
Utility of Prophylactic Cranial Irradiation for Limited Stage Small Cell Lung Cancer in the Modern Era with Magnetic Resonance Imaging Surveillance	11
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy	11
Ultrasound-guided Brachytherapy for Cervix Cancer	10
Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?	10
Recommendations for Multicentre Clinical Trials Involving Dosimetry for Molecular Radiotherapy	10
Global Longitudinal Strain for the Early Detection of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis	10
Role of Para-aortic Radiotherapy in the Management of Prostate Cancer	10
Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go?	10
Vertebral Fractures Following Stereotactic Body Radiotherapy for Spine Oligometastases: A Multi-institutional Analysis of Patient Outcomes	10
Multicentre Trials on Standardised Quantitative Imaging and Dosimetry for Radionuclide Therapies	10
Early Mortality after Radical Radiotherapy in Head and Neck Cancer – A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database	10
Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas	10
Prospective Longitudinal Assessment of Quality of Life and Activities of Daily Living as Patient-Reported Outcome Measures in Recurrent/Progressive Glioma Treated with High-dose Salvage Re-irradiation	10
Sexual and Psychosexual Consequences of Treatment for Gynaecological Cancers	10
Spine and Non-spine Bone Metastases – Current Controversies and Future Direction	10
Late Toxicity and Long-Term Local Control in Patients With Ultra-Central Lung Tumours Treated by Intensity-Modulated Radiotherapy-Based Stereotactic Ablative Body Radiotherapy With Homogenous Dose Pre	9
A Multicentre UK Study of Outcomes of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy ± Chemotherapy	9
Whole Brain Radiotherapy Versus Stereotactic Radiosurgery in Poor-Prognosis Patients with One to 10 Brain Metastases: A Randomised Feasibility Study	9
NOTCH: The National Oncology Trainees Collaborative for Healthcare Research	9
Evolving Practice Patterns Over Two Decades (1993–2013) in the Management of Desmoid-type Fibromatosis in British Columbia	9
Artificial Intelligence for Radiotherapy Auto-Contouring: Current Use, Perceptions of and Barriers to Implementation	9
Set-Up Errors, Organ Motion, Tumour Regression and its Implications on Internal Target Volume–Planning Target Volume During Cervical Cancer Radiotherapy: Results From a Prospective Study	9
Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer – Real-World Outcomes From UK Centres	9
Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer	9
Gender Differences and Their Effects on Survival Outcomes in Lung Cancer Patients Treated With PD-1/PD-L1 Checkpoint Inhibitors: A Systematic Review and Meta-Analysis	9
Stereotactic Body Radiotherapy Versus Metastasectomy in Patients With Pulmonary Metastases From Soft Tissue Sarcoma	9
The Changing Landscape for the Treatment of Painful Spinal Metastases: is Stereotactic Body Radiation Therapy the New Standard of Care?	9
Evaluation of Locoregional Recurrence Patterns Following Adjuvant (Chemo)Radiotherapy for Oral Cavity Carcinoma	9
Pencil Beam Scanning Proton Therapy Case Selection for Paediatric Abdominal Neuroblastoma: Effects of Tumour Location and Bowel Gas	9
Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice	9
Neutrophil–Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer	9
Pencil Beam Scanning Proton Therapy for Paediatric Neuroblastoma with Motion Mitigation Strategy for Moving Target Volumes	9
Smoking Cessation in Cancer Care: Myths, Presumptions and Implications for Practice	9
Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial	9
Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic – Rapid Review	8
A Predictive Model for Reactive Tube Feeding in Head and Neck Cancer Patients Undergoing Definitive (Chemo) Radiotherapy	8
Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electro	8
Impact of Concomitant Medications on Biochemical Outcome in Localised Prostate Cancer Treated with Radiotherapy and Androgen Deprivation Therapy	8
Scientific Developments in Imaging and Dosimetry for Molecular Radiotherapy	8
Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?	8
Peptide Receptor Radionuclide Therapy – Prospects for Personalised Treatment	8
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiation Therapy Compared With Surgery and Radiofrequency Ablation in Two Patient Cohorts: Metastatic Liver Cancer and Hepatocellular Carcino	8
A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy	8
Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and Toxicity	8
Personal View: Low-dose Lung Radiotherapy for COVID-19 Pneumonia – The Atypical Science and the Unknown Collateral Consequence	8
Education to Improve Cancer Care for LGBTQ+ Patients in the UK	8
Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)	8
Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study	8
How Useful is COVID-19 Antibody Testing – A Current Assessment for Oncologists	8
Estimating the Risk of Death from COVID-19 in Adult Cancer Patients	8
Surgical and Radiotherapeutic Management of Malignant Extradural Spinal Cord Compression	8
Complex Clinical Decision-Making Process of Re-Irradiation	8
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study	8
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial	7
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK	7
COVID RT – Assessing the Impact of COVID-19 on Radiotherapy in the UK. A National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Initiative in Partnership wit	7
Innovative Follow-up Strategies for Endometrial Cancer	7
The Response of the UK Clinical Oncology Community to the COVID-19 Pandemic	7
What Really Matters for Cancer Care – Health Systems Strengthening or Technological Innovation?	7
Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease	7
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?	7
Repurposing Radiation Therapy for Immuno-oncology	7
Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks	7
Implementation of Royal College of Radiologists Consensus Statements and National Institute for Health and Care Excellence Guidance: Breast Radiotherapy Practice in the UK	7
Adjuvant Therapy for High-risk Endometrial Carcinoma	7
Comparing the Ability of Physician-Reported Versus Patient-Reported Performance Status to Predict Survival in a Population-Based Cohort of Newly Diagnosed Cancer Patients	7
Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer	7
Functional Imaging to Predict Treatment Response in Head and Neck Cancer: How Close are We to Biologically Adaptive Radiotherapy?	7
Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment	7
Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today	7

From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy	7
Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy	7
Assessing Equity of Access to Proton Beam Therapy: A Literature Review	7
Sacral Insufficiency Fracture Following Pelvic Radiotherapy in Gynaecological Malignancies: Development of a Predictive Model	7
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years	7
The Rise of Supportive Oncology: A Revolution in Cancer Care	7
Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy	6
Mentorship Needs for Radiation Oncology Residents: Implications for Programme Design	6
Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses	6
Combined Radiotherapy and New Systemic Therapies – Have We Moved Beyond Palliation?	6
High Dose Rate Brachytherapy in High-Risk Localised Disease – Why Do Anything Else?	6
Safe and Ethical Artificial Intelligence in Radiotherapy – Lessons Learned From the Aviation Industry	6
Paediatric Molecular Radiotherapy: Challenges and Opportunities	6
Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study	6
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces	6
Audit of Molecular Mechanisms of Primary and Secondary Resistance to Various Generations of Tyrosine Kinase Inhibitors in Known Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Cancer Patie	6
On Target 2: Updated Guidance for Image-guided Radiotherapy	6
Early Diagnosis and Lung Cancer Screening	6
Review of Conventional and High Dose Rate Brain Radiation (FLASH): Neurobehavioural, Neurocognitive and Assessment Issues in Rodent Models	6
Is There a Benefit of Combining Immunotherapy and Radiotherapy in Bladder Cancer?	6
Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic	6
Effect of Neoadjuvant Therapy on the Functional Outcome of Patients With Rectal Cancer: A Systematic Review and Meta-Analysis	6
Venous Thromboembolism During Chemotherapy for Testicular Cancer: A Population-Based Study	6
Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer	6
Evaluation of Prognostic and Predictive Models in the Oncology Clinic	6
Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review	6
Optimal Timing for COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy?	6
Long-term Survival Outcomes of ‘Low Risk’ Ductal Carcinoma in situ from a Territory-wide Cancer Registry	6
Long-Term Outcomes After Linac Radiosurgery for Benign Meningiomas	6
Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19	6
Notch Inhibition: a Promising Strategy to Improve Radiosensitivity and Curability of Radiotherapy	6
Understanding Survival Analysis in Clinical Trials	6
Effect of Race and Ethnicity on Risk of Radiotherapy Toxicity and Implications for Radiogenomics	6
A Review of the Metrics Used to Assess Auto-Contouring Systems in Radiotherapy	6
Clinical Outcomes of Stereotactic Body Radiotherapy With Immediate Versus Delayed Hormone Therapy in Men With Oligometastatic Recurrence of Prostate Cancer	6
Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response	6
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes	6
Analysis of the Safety and Pregnancy Outcomes of Fertility-sparing Surgery in Ovarian Malignant Sex Cord-stromal Tumours: A Multicentre Retrospective Study	5
Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer	5
The Association of Clinical Characteristics and Tumour Markers With Image-Defined Risk Factors in the Management of Neuroblastoma in South Africa	5
Platinum-Based Chemotherapy ‘Rechallenge’ in Advanced Non-ovarian Solid Malignancies	5
Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?	5
The National Lung Cancer Audit: The Impact of COVID-19	5
The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer	5
What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?	5
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis	5
Variations in Demand across England for the Magnetic Resonance-Linac Technology, Simulated Utilising Local-level Demographic and Cancer Data in the Malthus Project	5
High Dose Rate Brachytherapy for Inoperable Endometrial Cancer: a Case Series and Systematic Review of the Literature	5
Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentr	5
Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers	5
Impact of Adjuvant Treatment in pN3 Penile Cancer	5
Leveraging Radiobiology for Arrhythmia Management: A New Treatment Paradigm?	5
Identifying Risk Factors for Anthracycline Chemotherapy-induced Phlebitis in Women with Breast Cancer: An Observational Study	5
An Overview of the Role of Radiotherapy in the Treatment of Small Cell Lung Cancer – A Mainstay of Treatment or a Modality in Decline?	5
Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing	5
Nurturing a Research-active Clinical Oncology Workforce: A Trainee Perspective	5
Medical Student Perspectives on Undergraduate Oncology Education in the UK	5
Predicting Response to Radiotherapy in Cancer-Induced Bone Pain: Cytokines as a Potential Biomarker?	5
Current Status of Anatomical Magnetic Resonance Imaging in Brachytherapy and External Beam Radiotherapy Planning and Delivery	5
The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study	5
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy	5
SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic	5
Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy	5
A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts	5
COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce	5
Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer – A Done Deal?	5
The Pattern of Care of Use of Nivolumab in Head and Neck Cancers – Audit From a Tertiary Cancer Centre	5
Evaluation of the Impact of Magnetic Resonance Imaging with Susceptibility-weighted Imaging for Screening and Surveillance of Radiation-induced Cavernomas in Long-term Survivors of Malignancy	5
Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review	5
SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treat	5
BONUS: the National Oncology Network for Students and Junior Doctors	5
When Less is More: The Rising Tide of Hypofractionation	4
Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic	4
Validation of a Fully Automated Hybrid Deep Learning Cardiac Substructure Segmentation Tool for Contouring and Dose Evaluation in Lung Cancer Radiotherapy	4
Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer	4
Effectiveness of Trastuzumab in Routine Clinical Practice: A Population-based Study of Patients with HER-2-positive Oesophageal, Gastroesophageal and Gastric Cancer	4
Trends and Correlates of Mean Lung Dose in Patients Receiving Breast Radiotherapy in a Single Institution from 2014 to 2018	4
Relationship of Urethral Dose and Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy	4
First-line Cemiplimab versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer Patients with at Least 50% Programmed Cell Death Receptor Ligand-1 Positivity: Analysis of Cost-effectiveness	4
Health Economic and Health Service Issues of Palliative Radiotherapy	4
Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care	4
Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era — The Early and Late Effects of Radiation and Cisplatin	4
Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy	4
Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study	4
Full Spectrum of Cancer Patients in SARS-CoV-2 Infection Still Being Described	4
A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population	4
Patient-derived Xenograft Models of Small Cell Lung Cancer for Therapeutic Development	4
The Impact of the Acute Phase of COVID-19 on Radiotherapy Demand in South East Wales	4
Overcoming Osimertinib Resistance in Advanced Non-small Cell Lung Cancer	4
A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus	4
Embracing Skill Mix in the Clinical Oncology Workforce – Capturing Impacts of Consultant Therapeutic Radiographers in the UK	4
Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes	4
Geometric and Dosimetric Evaluation of a Commercially Available Auto-segmentation Tool for Gross Tumour Volume Delineation in Locally Advanced Non-small Cell Lung Cancer: a Feasibility Study	4
Developing UK Guidance on How Long Men Should Abstain from Receiving Anal Sex before, During and after Interventions for Prostate Cancer	4
Patient-reported Experience Measure for Neuro-oncology Telephone Clinics during the COVID-19 Pandemic	4